Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Neoplasm Metastasis
×
Standard of Care
×
Clear all
Filters
3
NCT01468623
2023-07-19
PROFUSE
Myriad Genetic Laboratories, Inc.
Phase 4
Terminated
51 enrolled
NCT01129336
2014-05-20
MACS1295
Novartis
Phase 4
Completed
44 enrolled
10 charts